~~<i id='7B990329D6'><strike id='7B990329D6'><tt id='7B990329D6'><pre id='7B990329D6'></pre></tt></strike></i>~~

Home» Wikipedia» leisure time

leisure time

author：Wikipedia 2025-10-06 09:44:12 Page View：3

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Orchard's therapy for neuron disease in children wins FDA approval
Next article： Activists slam private health insurers over coverage restrictions

Wikipedia

BioMarin wins approval for gene therapy to treat hemophilia A

AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

Typhoon Doksuri makes landfall in China after bringing deadly landslides to Philippines

InthisphotoreleasedbyXinhuaNewsAgency,thisaerialphotoshowsfishingboatstakingshelterataharborasTyphoo

After affirmative action ruling, medical educators look to 'holistic review'

AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

Orchard's therapy for neuron disease in children wins FDA approval

AdobeTheFoodandDrugAdministrationonMondayapprovedagenetherapyformetachromaticleukodystrophy,adevasta